Common Stock
Odonate Therapeutics Inc
NASDAQ:ODT (1/14/2022, 7:44:12 PM)
After market: 1.11 -0.01 (-0.89%)1.12
-0.05 (-4.27%)
Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. The company is headquartered in New York City, New York and currently employs 137 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company is focused on the development of tesetaxel, a novel chemotherapy agent.
Odonate Therapeutics Inc
3 East 28Th Street, 10Th Floor
New York City NEW YORK 10016
P: 13322060935.0
CEO: Kevin Tang
Employees: 137
Website: https://www.odonate.com/
Here you can normally see the latest stock twits on ODT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: